Lenvima Lenvatinib Capsules 4 Mg Medicine Raw Materials

Lenvima is a professionally prescribed medication used to treat the side effects of differentiated thyroid cancer, progressed renal cell carcinoma, hepatocellular carcinoma, and endometrial cancer. Lenvima might be utilized alone or with different drugs. Lenvima has a place with a class of medications called antineoplastics, vegf inhibitor. Lenvatinib mesylate is a white to pale rosy yellow powder. It is marginally dissolvable in water and basically insoluble in ethanol (dried out). The separation steady of lenvatinib mesylate is 5.05 at 25A c. The segment coefficient (log p esteem) lenvima, a kinase inhibitor, is the mesylate salt of lenvatinib. Its synthetic name is 4-[3-chloro-4-(n'- cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide methanesulfonate.